Literature DB >> 6678307

Early response and long-term results in the radiotherapy of childhood medulloblastoma.

H W Chin, Y Maruyama.   

Abstract

Outcome results of 23 patients with childhood medulloblastomas were analyzed in relation to radiation technique and survival. No failures were noted when radiation dose of 5 400 rad was used; whereas none survived in the sub-group treated with less than 4 000 rad. The prognosis in the very young age group, less than three years old, was worse compared to the older child with a tendency to advanced disease at presentation. Quality of life in all survivors was satisfactory and long-term sequelae were surprisingly minimal in all aspects of physical, mental, and intellectual developments. Vertebral growth disturbance and short stature were the major late sequellae of successful radiotherapy.

Entities:  

Mesh:

Year:  1983        PMID: 6678307     DOI: 10.1007/bf00153642

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  15 in total

1.  Pituitary function in long-term survival after radiation therapy of nasopharyngeal tumours.

Authors:  A de Schryver; J G Ljunggren; I Båryd
Journal:  Acta Radiol Ther Phys Biol       Date:  1973-12

2.  Calvarial-scalp compensator for radiotherapy.

Authors:  Y Maruyama; P Wu; E Van Arsdale; J Utley; J Avila; D E Wrede
Journal:  Radiology       Date:  1975-10       Impact factor: 11.105

3.  Adjuvant chemotherapy for medulloblastoma and ependymoma using iv vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: a Southwest Oncology Group Study.

Authors:  J van Eys; T Chen; T Moore; W Cheek; C Sexauer; K Starling
Journal:  Cancer Treat Rep       Date:  1981 Jul-Aug

4.  Radiation treatment for medulloblastoma. A 21-year review.

Authors:  M P Berry; R D Jenkin; C W Keen; B D Nair; W J Simpson
Journal:  J Neurosurg       Date:  1981-07       Impact factor: 5.115

5.  Results of radiation treatment of cerebellar medulloblastoma.

Authors:  H W Chin; Y Maruyama
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-06       Impact factor: 7.038

6.  Medulloblastoma in children: a correlation between staging and results of treatment.

Authors:  L Harisiadis; C H Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Sep-Oct       Impact factor: 7.038

7.  Medulloblastoma: treatment results and effect on normal tissues.

Authors:  R L Cumberlin; K H Luk; W M Wara; G E Sheline; C B Wilson
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

8.  Generalized osteoblastic bony metastases from medulloblastoma.

Authors:  E P Ho; A Lieber; F H DeLand; Y Maruyama
Journal:  Oncology       Date:  1976       Impact factor: 2.935

9.  Medulloblastoma in childhood. Survival and functional results.

Authors:  J F Hirsch; D Renier; P Czernichow; L Benveniste; A Pierre-Kahn
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

10.  Combined treatment of pediatric medulloblastoma. A review of an integrated program )two-arm chemotherapy trial).

Authors:  M Gerosa; E DiStefano; M Carli; G Iraci
Journal:  Childs Brain       Date:  1980
View more
  4 in total

Review 1.  Medulloblastoma: a historical perspective and overview.

Authors:  J T Rutka; H J Hoffman
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

Review 2.  Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review.

Authors:  Thora Gudrunardottir; Birgitta Lannering; Marc Remke; Michael D Taylor; Elizabeth M Wells; Robert F Keating; Roger J Packer
Journal:  Childs Nerv Syst       Date:  2014-02-26       Impact factor: 1.475

3.  Medulloblastoma: survival and late recurrence after the Collins' risk period.

Authors:  S Nishio; T Morioka; I Takeshita; M Fukui
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

4.  Management of medulloblastoma in children, a multidisciplinary problem.

Authors:  G Broere
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.